IndiaTickerAptus Pharma Ltd - 544529 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Company dossier
Aptus Pharma
BSE:APPL · ISIN INE15XJ01010
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Aptus Pharma
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Aptus Pharma Ltd - 544529 - Announcement under Regulation 30 (LODR)-Credit RatingBSE · credit rating · pdf
Source filing Aptus Pharma Ltd - 544529 - Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th June, 2026BSE · exchange filing · pdf
Source filing Aptus Pharma Ltd - 544529 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Aptus Pharma Ltd - 544529 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Friday, June 12, 2026 And Intimation Regarding Closure Of Trading Window.BSE · exchange filing · pdf
Source filing Aptus Pharma Ltd - 544529 - Announcement under Regulation 30 (LODR)-Investor PresentationBSE · investor presentation · pdf
Source filing Aptus Pharma Ltd - 544529 - Brand Promotion Initiative At Rajkot Hirasar AirportBSE · exchange filing · pdf
Source filing Aptus Pharma Ltd - 544529 - Disclosure As Per Regulation 7(2) Of SEBI (PIT) Regulations, 2015BSE · exchange filing · pdf
Source filing Aptus Pharma Ltd - 544529 - Disclosures under Reg. 29(1) / 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Aptus Pharma Ltd - 544529 - Disclosures under Reg. 29(1) / 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Aptus Pharma Ltd - 544529 - Disclosures under Reg. 29(1) / 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Aptus Pharma Ltd - 544529 - Disclosures under Reg. 29(1) / 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Aptus Pharma Ltd - 544529 - Disclosures under Reg. 29(1) / 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Aptus Pharma Ltd - 544529 - Disclosures under Reg. 29(1) / 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Aptus Pharma Ltd - 544529 - Disclosures under Reg. 29(1) / 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Aptus Pharma Ltd - 544529 - Disclosures under Reg. 29(1) / 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Aptus Pharma Ltd - 544529 - Disclosures under Reg. 29(1) / 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Aptus Pharma Ltd - 544529 - Announcement under Regulation 30 (LODR)-Monitoring Agency ReportBSE · exchange filing · pdf
Source filing Aptus Pharma Ltd - 544529 - Statement Of Deviation(S) Or Variation(S) In Utilization Of Proceeds Of Initial Public Offer Pursuant To Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015BSE · exchange filing · pdf
Source filing Aptus Pharma Ltd - 544529 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · financial results · pdf
Source filing Aptus Pharma Ltd - 544529 - Intimation Of Record Date For Issue Of Bonus SharesBSE · exchange filing · pdf
Source filing Aptus Pharma Ltd - 544529 - Audited Financial Results For The Half Year And Year Ended On 31St March, 2026BSE · financial results · pdf
Source filing Aptus Pharma Ltd - 544529 - Board Meeting Outcome for Outcome Of Board Meeting Held On 27Th April, 2026.BSE · exchange filing · pdf
Source filing Aptus Pharma Ltd - 544529 - Disclosure Regarding Non-Applicability Of Regulation 24A Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015BSE · exchange filing · pdf
Source filing Aptus Pharma Ltd - 544529 - Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotBSE · exchange filing · pdf
Source filing Aptus Pharma Ltd - 544529 - Board Meeting Intimation for Intimation Of Board Meeting For Consideration Of Audited Financial Results For The Half Year/Year Ended On March 31, 2026 And Closure Of Trading Window.BSE · financial results · pdf
Source filing Aptus Pharma Ltd - 544529 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Aptus Pharma Ltd - 544529 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Aptus Pharma Ltd - 544529 - Newspaper Advertisement Of Notice Of Postal Ballot And E-Voting InformationBSE · exchange filing · pdf
Source filing Aptus Pharma Ltd - 544529 - Board Meeting Outcome for Revised Outcome Of Board Meeting Held On 24/03/2026 Incorporating Additional Details In Compliance With SEBI Circular No. SEBI/HO/CFD/Pod2/CIR/P/0155 Dated November 11, 2024.BSE · exchange filing · pdf
Source filing Aptus Pharma Ltd - 544529 - Shareholder Meeting / Postal Ballot-Notice of Postal BallotBSE · exchange filing · pdf
Source filing Aptus Pharma Ltd - 544529 - Board Meeting Outcome for Outcome Of Board Meeting Held On March 24, 2026BSE · exchange filing · pdf
Source filing Aptus Pharma Ltd - 544529 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Aptus Pharma Ltd - 544529 - Board Meeting Intimation for Prior Intimation Of Board Meeting To Be Held On Tuesday, March 24, 2026BSE · exchange filing · pdf
Source filing Aptus Pharma Ltd - 544529 - Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015: Business ExpansionBSE · exchange filing · pdf
Source filing Aptus Pharma Ltd - 544529 - Intimation Of Award Received: Recognition As Fastest Growing Ethical Pharma CompanyBSE · exchange filing · pdf
Source filing Aptus Pharma Ltd - 544529 - Announcement under Regulation 30 (LODR)-Investor PresentationBSE · investor presentation · pdf
Source filing Aptus Pharma Ltd - 544529 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Aptus Pharma Ltd - 544529 - Press Release- Aptus Pharma Expands OTC Presence In Gujarat, Strengthens Cosmeceutical PortfolioBSE · exchange filing · pdf
Source filing Aptus Pharma Ltd - 544529 - Regulation 30 Disclosure - Entry Into The Urology Therapy SegmentBSE · exchange filing · pdf
Source filing